Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Correction to: Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients.

Garde-Noguera J, Martin-Martorell P, De Julián M, Perez-Altozano J, Salvador-Coloma C, García-Sanchez J, Insa-Molla A, Martín M, Mielgo-Rubio X, Marin-Liebana S, Blasco-Cordellat A, Blasco-Molla S, Gironés R, Marquez-Medina D, Aparisi F, Cerda MCB, Macia-Escalante S, Sánchez A, Juan-Vidal O.

Clin Transl Oncol. 2018 Jul 9. doi: 10.1007/s12094-018-1916-2. [Epub ahead of print]

PMID:
29987667
2.

Massive Hemoptysis after the First Administration of Pembrolizumab in a Strongly Positive, Centrally Located NSCLC.

Artal-Cortés A, Felices-Lobera P, Márquez-Medina D.

J Thorac Oncol. 2018 May;13(5):e76-e77. doi: 10.1016/j.jtho.2017.12.004. No abstract available.

PMID:
29703541
3.

Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients.

Garde-Noguera J, Martin-Martorell P, De Julián M, Perez-Altozano J, Salvador-Coloma C, García-Sanchez J, Insa-Molla A, Martín M, Mielgo-Rubio X, Marin-Liebana S, Blasco-Cordellat A, Blasco-Molla S, Gironés R, Marquez-Medina D, Aparisi F, Cerda MCB, Macia-Escalante S, Sánchez A, Juan-Vidal O.

Clin Transl Oncol. 2018 Aug;20(8):1072-1079. doi: 10.1007/s12094-017-1829-5. Epub 2018 Jan 24. Erratum in: Clin Transl Oncol. 2018 Jul 9;:.

PMID:
29368144
4.

Increase in neoplastic disease in patients with chronic obstructive pulmonary disease. Two not so unrelated entities.

Márquez Medina D, Artal Cortés A.

Rev Clin Esp. 2017 Oct;217(7):396-397. doi: 10.1016/j.rce.2017.09.002. English, Spanish. No abstract available.

PMID:
28964322
5.

Eventual role of EGFR-tyrosine kinase inhibitors in early-stage non-small-cell lung cancer.

Marquez-Medina D, Popat S.

Future Oncol. 2016 Mar;12(6):815-25. doi: 10.2217/fon.15.356. Epub 2016 Feb 1. Review.

PMID:
26829230
6.

Closing faucets: the role of anti-angiogenic therapies in malignant pleural diseases.

Marquez-Medina D, Popat S.

Clin Transl Oncol. 2016 Aug;18(8):760-8. doi: 10.1007/s12094-015-1464-y. Epub 2015 Dec 17. Review.

PMID:
26680633
7.

Systemic therapy for pulmonary carcinoids.

Marquez-Medina D, Popat S.

Lung Cancer. 2015 Nov;90(2):139-47. doi: 10.1016/j.lungcan.2015.08.018. Epub 2015 Sep 12. Review.

PMID:
26371699
8.

Afatinib: a second-generation EGF receptor and ErbB tyrosine kinase inhibitor for the treatment of advanced non-small-cell lung cancer.

Marquez-Medina D, Popat S.

Future Oncol. 2015 Sep;11(18):2525-40. doi: 10.2217/fon.15.183. Epub 2015 Aug 28. Review.

PMID:
26314834
9.

Watch the weathercock: changes in re-staging 18F-FDG PET/CT scan predict the probability of relapse in locally advanced non-small cell lung cancer.

Marquez-Medina D, Martin-Marco A, Popat S.

Clin Transl Oncol. 2016 Feb;18(2):228-32. doi: 10.1007/s12094-015-1349-0. Epub 2015 Jul 24.

PMID:
26203801
10.

Little things make big things happen: angiolymphatic invasion and tumor necrosis prognosticate the outcome of locally advanced non-small cell lung cancer treated with a prior induction therapy.

Marquez-Medina D, Martin-Marco A, Caldero SG, Montero-Fernandez A.

Am J Clin Pathol. 2015 Jun;143(6):889-94. doi: 10.1309/AJCPYQ8V3BXSWRWG.

PMID:
25972332
11.

Age does not worsen the efficacy nor tolerance to combined induction therapies in locally advanced non-small cell lung cancer.

Marquez-Medina D, Martin-Marco A, Ojanguren-Garranz A.

Anticancer Res. 2014 Aug;34(8):4373-6.

PMID:
25075074
12.

Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: a new era begins.

Remon J, Morán T, Majem M, Reguart N, Dalmau E, Márquez-Medina D, Lianes P.

Cancer Treat Rev. 2014 Feb;40(1):93-101. doi: 10.1016/j.ctrv.2013.06.002. Epub 2013 Jul 3. Review.

PMID:
23829935
13.

Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer.

Schmid-Bindert G, Gebbia V, Mayer F, Arriola E, Márquez-Medina D, Syrigos K, Biesma B, Leschinger MI, Frimodt-Moller B, Ripoche V, Myrand SP, Nguyen TS, Hozak RR, Zimmermann A, Visseren-Grul C, Schuette W.

Lung Cancer. 2013 Sep;81(3):428-34. doi: 10.1016/j.lungcan.2013.05.010. Epub 2013 Jun 20.

PMID:
23790468
14.

Continued erlotinib maintenance and salvage radiation for solitary areas of disease progression: a useful strategy in selected non-small cell lung cancers?

Marquez-Medina D, Chachoua A, Martin-Marco A, Desai AM, Garcia-Reglero V, Salud-Salvia A, Muggia F.

Clin Transl Oncol. 2013 Nov;15(11):959-64. doi: 10.1007/s12094-013-1035-z. Epub 2013 Apr 20.

PMID:
23606352
15.

[Are the neuropsychological alterations in eating disorders endophenotypes of the disease? Review and state of the art].

Idini E, Marquez-Medina D, Pifarre J, Buj-Alvarez I, Castan-Campanera E.

Rev Neurol. 2012 Dec 16;55(12):729-36. Review. Spanish.

16.

Role of gamma-delta T-cells in cancer: another opening door to immunotherapy.

Marquez-Medina D, Salla-Fortuny J, Salud-Salvia A.

Clin Transl Oncol. 2012 Dec;14(12):891-5. doi: 10.1007/s12094-012-0935-7. Epub 2012 Oct 2. Review.

PMID:
23054752
17.

Human papillomavirus in non-small-cell lung cancer: the impact of EGFR mutations and the response to erlotinib.

Márquez-Medina D, Gasol-Cudós A, Taberner-Bonastre MT, Samamé Pérez-Vargas JC, Salud-Salvia A, Llombart-Cussac A.

Arch Bronconeumol. 2013 Feb;49(2):79-81. doi: 10.1016/j.arbres.2012.04.003. Epub 2012 May 22. English, Spanish.

18.

Pleural epithelioid hemangioendothelioma in an elderly patient. A case report and review of the literature.

Márquez-Medina D, Samamé-Pérezvargas JC, Tuset-DerAbrain N, Montero-Fernández A, Taberner-Bonastre T, Porcel JM.

Lung Cancer. 2011 Jul;73(1):116-9. doi: 10.1016/j.lungcan.2011.04.003. Epub 2011 May 17. Review.

PMID:
21592613
19.

Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study.

Brieva-Ruíz L, Diaz-Hurtado M, Matias-Guiu X, Márquez-Medina D, Tarragona J, Graus F.

Clin Neurol Neurosurg. 2008 Dec;110(10):1044-6. doi: 10.1016/j.clineuro.2008.06.016. Epub 2008 Aug 13.

PMID:
18701208
20.

[Paraneoplasic cerebellar degeneration as a presentation of breast cancer recurrence].

Gázquez Sisteré I, Caro Orozco S, Márquez Medina D, Chordá Ribelles J, Quílez Martínez A.

An Med Interna. 2007 Mar;24(3):132-4. Review. Spanish.

PMID:
17590135

Supplemental Content

Loading ...
Support Center